Story perspectives

3-Year-Old First to Receive Groundbreaking Hunter Syndrome Therapy

11/29/2025

22 2

Summary

Story summary

Oliver Chu, a 3-year-old from California, became the first child to receive autologous hematopoietic stem cell gene therapy for Hunter syndrome at Royal Manchester Children's Hospital.
The therapy replaced the faulty Hunter syndrome gene.
Three months after treatment, Oliver has shown improvement, with his mother expressing joy.
Skyler, Oliver's brother, has Hunter syndrome and is too old for this treatment.
The trial's success raises hopes for therapies for older patients.

1 of 1

Story summary

Oliver Chu, a 3-year-old from California, became the first child to receive autologous hematopoietic stem cell gene therapy for Hunter syndrome at Royal Manchester Children's Hospital.
The therapy replaced the faulty Hunter syndrome gene.
Three months after treatment, Oliver has shown improvement, with his mother expressing joy.
Skyler, Oliver's brother, has Hunter syndrome and is too old for this treatment.
The trial's success raises hopes for therapies for older patients.